Trial intelligence / Profile preview

SK-1405 in Hemodialysis Patients with Uremic Pruritus

NCT03218501Phase 2Completed

Sponsor
Sanwa Kagaku Kenkyusho Co., Ltd.
Start
Aug 2017
Primary completion
May 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of SK-1405 in uremic pruritus, sponsored by Sanwa Kagaku Kenkyusho Co., Ltd.. Started Aug 2017; status: completed.

02

Drugs

SK-1405
03

Conditions

uremic pruritus

Beyond the preview

Go deeper on NCT03218501.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03218501.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call